Silka Antifungal

Manufacturer
Genomma Lab USA
Effective date
2022-03-23
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:48:54

Label at a glance#

ProductSilka Antifungal
Active ingredientTolnaftate
Label structure11 sections

Indications and uses

For effective treatment of most athlete's foot and ringworm Relieves itching, scaling, cracking, burning, redness, soreness, irritation and discomfort. Helps prevent most athlete's foot (dermatophytosis) with daily use.

Dosage and administration

This product is not effective on the scalp or nails. For athlete's foot and ringworm: use daily for 4 weeks. Clean the affected area and dry thoroughly Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor Supervise children in the use of this product For athlete's foot: Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes an...

Storage and handling

Store at room temperature 15° – 30°C (59° -86°F)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Tolnaftate 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

  • For effective treatment of most athlete's foot and ringworm
  • Relieves itching, scaling, cracking, burning, redness, soreness, irritation and discomfort. Helps prevent most athlete's foot (dermatophytosis) with daily use.

Warnings

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

  • Do not use on children under 2 years of age unless directed by a doctor.

OTC - WHEN USING SECTION

When using this product avoid contact with the eyes.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • irritation occurs
  • there is no improvement within 4 weeks (for athlete's foot and ringworm).

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • This product is not effective on the scalp or nails. For athlete's foot and ringworm: use daily for 4 weeks. Clean the affected area and dry thoroughly
  • Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor
  • Supervise children in the use of this product
  • For athlete's foot: Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once daily
  • To prevent athlete's foot, apply once or twice daily (morning and/or night)
  • Apply to skin around the nail and cuticle.

Other information

STORAGE AND HANDLING SECTION

  • Store at room temperature 15° – 30°C (59° -86°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aloe Barbadensis Leaf Extract, BHT, Carthamus Tinctorius (Safflower) Seed Oil, Hydrogenated Polyisobutene, Lavandula Angustifolia (Lavender) Oil, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Oryza Sativa (Rice) Bran Oil, Prunus Amygdalus Dulcis (Sweet Almond) Oil, Sesamum Indicum (Sesame) Seed Oil, Simmondsia Chinensis (Jojoba) Seed Oil, Tocopheryl Acetate.

Questions or comments?

OTC - QUESTIONS SECTION

Call toll free 1-877-994-3666

Monday to Friday, 8 am to 6 pm Central time.

SPL UNCLASSIFIED SECTION

Distributed by:
Genomma Lab., Houston, TX 77027

PRINCIPAL DISPLAY PANEL - 13 ML Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SILKA®

MAX STRENGTH

ANTIFUNGAL
LIQUID

  1. KILLS
    FUNGUS
  2. STOPS ITCHING
    AND BURNING
  3. HELPS RESTORE
    SKIN HEALTH

BEFORE
AFTER
DRAMATIZATION

WITH BRUSH
APPLICATOR

CLINICALLY PROVEN
AGAINST ATHLETE'S
FOOT FUNGUS

0.45 FL OZ / 13 ML

PRINCIPAL DISPLAY PANEL - 13 ML Bottle Carton
PRINCIPAL DISPLAY PANEL - 13 ML Bottle Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2704862SILKA 1 % Topical SolutionPSN2
313423tolnaftate 1 % Topical SolutionPSN2
2704862tolnaftate 10 MG/ML Topical Solution [Silka Antifungal]SBD2
313423tolnaftate 10 MG/ML Topical SolutionSCD2
2704862Silka Antifungal 10 MG/ML Topical SolutionSY2
313423tolnaftate 1 % Topical SolutionSY2

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50066-083-012025-01-30C16284748780-12cef2736-96f4-d83d-e063-dadaa90ab31fSilka ® Antifungal Liquid

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50066-083-01Silka Antifungal13 mL in 1 BOTTLE, GLASSLIQUID132
50066-083-01Silka Antifungal1 in 1 CARTONLIQUID12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50066-083SILKA ANTIFUNGAL (TOLNAFTATE) LIQUID [GENOMMA LAB USA]2Legacy NDC, 2 package rows20220325_550d2a9b-4b23-47e5-9dc6-df1fc39a0f21.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50066-08350066-083-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e90b344a-8558-4061-9fbe-2f89b219b97b550d2a9b-4b23-47e5-9dc6-df1fc39a0f212022-03-23WarningsExact identifier
spl id: e90b344a-8558-4061-9fbe-2f89b219b97b
spl set id: 550d2a9b-4b23-47e5-9dc6-df1fc39a0f21

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.